nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Vinblastine—Vincristine—colon cancer	0.023	1	CbGdCrCtD
Tizanidine—Back pain—Irinotecan—colon cancer	0.00186	0.00191	CcSEcCtD
Tizanidine—Muscle spasms—Irinotecan—colon cancer	0.00185	0.0019	CcSEcCtD
Tizanidine—Asthma—Capecitabine—colon cancer	0.00185	0.00189	CcSEcCtD
Tizanidine—Influenza—Capecitabine—colon cancer	0.00185	0.00189	CcSEcCtD
Tizanidine—Dysphagia—Capecitabine—colon cancer	0.00185	0.00189	CcSEcCtD
Tizanidine—Anaemia—Vincristine—colon cancer	0.00183	0.00187	CcSEcCtD
Tizanidine—Agitation—Vincristine—colon cancer	0.00182	0.00186	CcSEcCtD
Tizanidine—Angina pectoris—Capecitabine—colon cancer	0.0018	0.00185	CcSEcCtD
Tizanidine—Ill-defined disorder—Irinotecan—colon cancer	0.00179	0.00183	CcSEcCtD
Tizanidine—Anaemia—Irinotecan—colon cancer	0.00178	0.00182	CcSEcCtD
Tizanidine—Bronchitis—Capecitabine—colon cancer	0.00178	0.00182	CcSEcCtD
Tizanidine—Vertigo—Vincristine—colon cancer	0.00178	0.00182	CcSEcCtD
Tizanidine—Hepatic failure—Methotrexate—colon cancer	0.00177	0.00182	CcSEcCtD
Tizanidine—Leukopenia—Vincristine—colon cancer	0.00177	0.00181	CcSEcCtD
Tizanidine—Vision blurred—Fluorouracil—colon cancer	0.00174	0.00178	CcSEcCtD
Tizanidine—Malaise—Irinotecan—colon cancer	0.00174	0.00178	CcSEcCtD
Tizanidine—Vertigo—Irinotecan—colon cancer	0.00173	0.00177	CcSEcCtD
Tizanidine—Syncope—Irinotecan—colon cancer	0.00173	0.00177	CcSEcCtD
Tizanidine—Renal failure acute—Methotrexate—colon cancer	0.00173	0.00177	CcSEcCtD
Tizanidine—Leukopenia—Irinotecan—colon cancer	0.00173	0.00177	CcSEcCtD
Tizanidine—Convulsion—Vincristine—colon cancer	0.00171	0.00175	CcSEcCtD
Tizanidine—Hypertension—Vincristine—colon cancer	0.00171	0.00175	CcSEcCtD
Tizanidine—Anaemia—Fluorouracil—colon cancer	0.00171	0.00175	CcSEcCtD
Tizanidine—Loss of consciousness—Irinotecan—colon cancer	0.00169	0.00173	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00169	0.00173	CcSEcCtD
Tizanidine—Weight decreased—Capecitabine—colon cancer	0.00167	0.00171	CcSEcCtD
Tizanidine—Hyperglycaemia—Capecitabine—colon cancer	0.00167	0.00171	CcSEcCtD
Tizanidine—Hypertension—Irinotecan—colon cancer	0.00166	0.0017	CcSEcCtD
Tizanidine—Pneumonia—Capecitabine—colon cancer	0.00166	0.0017	CcSEcCtD
Tizanidine—Leukopenia—Fluorouracil—colon cancer	0.00165	0.00169	CcSEcCtD
Tizanidine—Depression—Capecitabine—colon cancer	0.00165	0.00168	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00164	0.00167	CcSEcCtD
Tizanidine—Acute coronary syndrome—Capecitabine—colon cancer	0.00163	0.00167	CcSEcCtD
Tizanidine—Cerebrovascular accident—Methotrexate—colon cancer	0.00163	0.00167	CcSEcCtD
Tizanidine—Renal failure—Capecitabine—colon cancer	0.00162	0.00166	CcSEcCtD
Tizanidine—Discomfort—Irinotecan—colon cancer	0.00162	0.00166	CcSEcCtD
Tizanidine—Myocardial infarction—Capecitabine—colon cancer	0.00162	0.00166	CcSEcCtD
Tizanidine—Neuropathy peripheral—Capecitabine—colon cancer	0.00162	0.00166	CcSEcCtD
Tizanidine—Anaphylactic shock—Vincristine—colon cancer	0.00161	0.00165	CcSEcCtD
Tizanidine—Oedema—Vincristine—colon cancer	0.00161	0.00165	CcSEcCtD
Tizanidine—Jaundice—Capecitabine—colon cancer	0.00161	0.00165	CcSEcCtD
Tizanidine—Infection—Vincristine—colon cancer	0.0016	0.00164	CcSEcCtD
Tizanidine—Conjunctivitis—Capecitabine—colon cancer	0.0016	0.00164	CcSEcCtD
Tizanidine—Convulsion—Fluorouracil—colon cancer	0.0016	0.00164	CcSEcCtD
Tizanidine—Confusional state—Irinotecan—colon cancer	0.00159	0.00162	CcSEcCtD
Tizanidine—Nervous system disorder—Vincristine—colon cancer	0.00158	0.00162	CcSEcCtD
Tizanidine—Thrombocytopenia—Vincristine—colon cancer	0.00158	0.00162	CcSEcCtD
Tizanidine—Haematuria—Capecitabine—colon cancer	0.00157	0.00161	CcSEcCtD
Tizanidine—Anaphylactic shock—Irinotecan—colon cancer	0.00157	0.00161	CcSEcCtD
Tizanidine—Oedema—Irinotecan—colon cancer	0.00157	0.00161	CcSEcCtD
Tizanidine—Infection—Irinotecan—colon cancer	0.00156	0.0016	CcSEcCtD
Tizanidine—Hyperhidrosis—Vincristine—colon cancer	0.00156	0.0016	CcSEcCtD
Tizanidine—Hepatobiliary disease—Capecitabine—colon cancer	0.00156	0.0016	CcSEcCtD
Tizanidine—Discomfort—Fluorouracil—colon cancer	0.00155	0.00159	CcSEcCtD
Tizanidine—Shock—Irinotecan—colon cancer	0.00155	0.00158	CcSEcCtD
Tizanidine—Nervous system disorder—Irinotecan—colon cancer	0.00154	0.00158	CcSEcCtD
Tizanidine—Agranulocytosis—Capecitabine—colon cancer	0.00154	0.00158	CcSEcCtD
Tizanidine—Thrombocytopenia—Irinotecan—colon cancer	0.00154	0.00158	CcSEcCtD
Tizanidine—Hyperhidrosis—Irinotecan—colon cancer	0.00152	0.00156	CcSEcCtD
Tizanidine—Confusional state—Fluorouracil—colon cancer	0.00152	0.00155	CcSEcCtD
Tizanidine—Mood swings—Methotrexate—colon cancer	0.00151	0.00155	CcSEcCtD
Tizanidine—Hypotension—Vincristine—colon cancer	0.00151	0.00154	CcSEcCtD
Tizanidine—Bradycardia—Capecitabine—colon cancer	0.00151	0.00154	CcSEcCtD
Tizanidine—Anaphylactic shock—Fluorouracil—colon cancer	0.00151	0.00154	CcSEcCtD
Tizanidine—Oedema—Fluorouracil—colon cancer	0.00151	0.00154	CcSEcCtD
Tizanidine—Infection—Fluorouracil—colon cancer	0.0015	0.00153	CcSEcCtD
Tizanidine—Haemoglobin—Capecitabine—colon cancer	0.00149	0.00152	CcSEcCtD
Tizanidine—Rhinitis—Capecitabine—colon cancer	0.00149	0.00152	CcSEcCtD
Tizanidine—Hepatitis—Capecitabine—colon cancer	0.00148	0.00152	CcSEcCtD
Tizanidine—Haemorrhage—Capecitabine—colon cancer	0.00148	0.00152	CcSEcCtD
Tizanidine—Nervous system disorder—Fluorouracil—colon cancer	0.00148	0.00151	CcSEcCtD
Tizanidine—Thrombocytopenia—Fluorouracil—colon cancer	0.00147	0.00151	CcSEcCtD
Tizanidine—Liver function test abnormal—Methotrexate—colon cancer	0.00147	0.00151	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00147	0.00151	CcSEcCtD
Tizanidine—Pharyngitis—Capecitabine—colon cancer	0.00147	0.00151	CcSEcCtD
Tizanidine—Tachycardia—Fluorouracil—colon cancer	0.00147	0.0015	CcSEcCtD
Tizanidine—Hypotension—Irinotecan—colon cancer	0.00147	0.0015	CcSEcCtD
Tizanidine—Urinary tract disorder—Capecitabine—colon cancer	0.00146	0.0015	CcSEcCtD
Tizanidine—Connective tissue disorder—Capecitabine—colon cancer	0.00146	0.00149	CcSEcCtD
Tizanidine—Urethral disorder—Capecitabine—colon cancer	0.00145	0.00149	CcSEcCtD
Tizanidine—Paraesthesia—Vincristine—colon cancer	0.00145	0.00148	CcSEcCtD
Tizanidine—Paraesthesia—Irinotecan—colon cancer	0.00141	0.00145	CcSEcCtD
Tizanidine—Hypotension—Fluorouracil—colon cancer	0.00141	0.00144	CcSEcCtD
Tizanidine—Dyspnoea—Irinotecan—colon cancer	0.0014	0.00144	CcSEcCtD
Tizanidine—Erythema multiforme—Capecitabine—colon cancer	0.0014	0.00143	CcSEcCtD
Tizanidine—Somnolence—Irinotecan—colon cancer	0.0014	0.00143	CcSEcCtD
Tizanidine—Fatigue—Vincristine—colon cancer	0.00139	0.00143	CcSEcCtD
Tizanidine—Dyspepsia—Irinotecan—colon cancer	0.00138	0.00142	CcSEcCtD
Tizanidine—Tinnitus—Capecitabine—colon cancer	0.00138	0.00141	CcSEcCtD
Tizanidine—Constipation—Vincristine—colon cancer	0.00138	0.00141	CcSEcCtD
Tizanidine—Asthma—Methotrexate—colon cancer	0.00138	0.00141	CcSEcCtD
Tizanidine—Cardiac disorder—Capecitabine—colon cancer	0.00138	0.00141	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00137	0.0014	CcSEcCtD
Tizanidine—Fatigue—Irinotecan—colon cancer	0.00136	0.00139	CcSEcCtD
Tizanidine—Paraesthesia—Fluorouracil—colon cancer	0.00135	0.00138	CcSEcCtD
Tizanidine—Constipation—Irinotecan—colon cancer	0.00134	0.00138	CcSEcCtD
Tizanidine—Angiopathy—Capecitabine—colon cancer	0.00134	0.00138	CcSEcCtD
Tizanidine—Dyspnoea—Fluorouracil—colon cancer	0.00134	0.00137	CcSEcCtD
Tizanidine—Somnolence—Fluorouracil—colon cancer	0.00134	0.00137	CcSEcCtD
Tizanidine—Immune system disorder—Capecitabine—colon cancer	0.00134	0.00137	CcSEcCtD
Tizanidine—Mediastinal disorder—Capecitabine—colon cancer	0.00134	0.00137	CcSEcCtD
Tizanidine—Dyspepsia—Fluorouracil—colon cancer	0.00133	0.00136	CcSEcCtD
Tizanidine—Arrhythmia—Capecitabine—colon cancer	0.00132	0.00135	CcSEcCtD
Tizanidine—Gastrointestinal pain—Vincristine—colon cancer	0.00132	0.00135	CcSEcCtD
Tizanidine—Alopecia—Capecitabine—colon cancer	0.00131	0.00134	CcSEcCtD
Tizanidine—Mental disorder—Capecitabine—colon cancer	0.0013	0.00133	CcSEcCtD
Tizanidine—Feeling abnormal—Irinotecan—colon cancer	0.0013	0.00133	CcSEcCtD
Tizanidine—Gastrointestinal pain—Irinotecan—colon cancer	0.00129	0.00132	CcSEcCtD
Tizanidine—Body temperature increased—Vincristine—colon cancer	0.00128	0.00131	CcSEcCtD
Tizanidine—Abdominal pain—Vincristine—colon cancer	0.00128	0.00131	CcSEcCtD
Tizanidine—Flatulence—Capecitabine—colon cancer	0.00127	0.0013	CcSEcCtD
Tizanidine—Back pain—Capecitabine—colon cancer	0.00125	0.00128	CcSEcCtD
Tizanidine—Abdominal pain—Irinotecan—colon cancer	0.00124	0.00127	CcSEcCtD
Tizanidine—Body temperature increased—Irinotecan—colon cancer	0.00124	0.00127	CcSEcCtD
Tizanidine—Feeling abnormal—Fluorouracil—colon cancer	0.00124	0.00127	CcSEcCtD
Tizanidine—Muscle spasms—Capecitabine—colon cancer	0.00124	0.00127	CcSEcCtD
Tizanidine—Pneumonia—Methotrexate—colon cancer	0.00124	0.00126	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—colon cancer	0.00123	0.00126	CcSEcCtD
Tizanidine—Depression—Methotrexate—colon cancer	0.00123	0.00125	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00122	0.00125	CcSEcCtD
Tizanidine—Vision blurred—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Tizanidine—Tremor—Capecitabine—colon cancer	0.00121	0.00124	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—colon cancer	0.00121	0.00124	CcSEcCtD
Tizanidine—Ill-defined disorder—Capecitabine—colon cancer	0.0012	0.00122	CcSEcCtD
Tizanidine—Urticaria—Fluorouracil—colon cancer	0.0012	0.00122	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—colon cancer	0.00119	0.00122	CcSEcCtD
Tizanidine—Anaemia—Capecitabine—colon cancer	0.00119	0.00122	CcSEcCtD
Tizanidine—Body temperature increased—Fluorouracil—colon cancer	0.00119	0.00122	CcSEcCtD
Tizanidine—Hypersensitivity—Vincristine—colon cancer	0.00119	0.00122	CcSEcCtD
Tizanidine—Sweating—Methotrexate—colon cancer	0.00118	0.00121	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—colon cancer	0.00117	0.0012	CcSEcCtD
Tizanidine—Malaise—Capecitabine—colon cancer	0.00116	0.00119	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—colon cancer	0.00116	0.00119	CcSEcCtD
Tizanidine—Vertigo—Capecitabine—colon cancer	0.00116	0.00119	CcSEcCtD
Tizanidine—Hypersensitivity—Irinotecan—colon cancer	0.00116	0.00119	CcSEcCtD
Tizanidine—Asthenia—Vincristine—colon cancer	0.00116	0.00119	CcSEcCtD
Tizanidine—Syncope—Capecitabine—colon cancer	0.00116	0.00118	CcSEcCtD
Tizanidine—Leukopenia—Capecitabine—colon cancer	0.00115	0.00118	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Tizanidine—Loss of consciousness—Capecitabine—colon cancer	0.00113	0.00116	CcSEcCtD
Tizanidine—Asthenia—Irinotecan—colon cancer	0.00113	0.00115	CcSEcCtD
Tizanidine—Hypertension—Capecitabine—colon cancer	0.00111	0.00114	CcSEcCtD
Tizanidine—Hypersensitivity—Fluorouracil—colon cancer	0.00111	0.00114	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—colon cancer	0.00111	0.00113	CcSEcCtD
Tizanidine—Diarrhoea—Vincristine—colon cancer	0.0011	0.00113	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—colon cancer	0.0011	0.00113	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—colon cancer	0.0011	0.00113	CcSEcCtD
Tizanidine—Arthralgia—Capecitabine—colon cancer	0.0011	0.00112	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—colon cancer	0.00109	0.00112	CcSEcCtD
Tizanidine—Anxiety—Capecitabine—colon cancer	0.00109	0.00112	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00109	0.00112	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—colon cancer	0.00109	0.00111	CcSEcCtD
Tizanidine—Discomfort—Capecitabine—colon cancer	0.00108	0.00111	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—colon cancer	0.00108	0.00111	CcSEcCtD
Tizanidine—Diarrhoea—Irinotecan—colon cancer	0.00108	0.0011	CcSEcCtD
Tizanidine—Dry mouth—Capecitabine—colon cancer	0.00107	0.0011	CcSEcCtD
Tizanidine—Dizziness—Vincristine—colon cancer	0.00107	0.00109	CcSEcCtD
Tizanidine—Pruritus—Fluorouracil—colon cancer	0.00107	0.00109	CcSEcCtD
Tizanidine—Confusional state—Capecitabine—colon cancer	0.00106	0.00109	CcSEcCtD
Tizanidine—Oedema—Capecitabine—colon cancer	0.00105	0.00108	CcSEcCtD
Tizanidine—Infection—Capecitabine—colon cancer	0.00105	0.00107	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—colon cancer	0.00104	0.00107	CcSEcCtD
Tizanidine—Dizziness—Irinotecan—colon cancer	0.00104	0.00106	CcSEcCtD
Tizanidine—Shock—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Tizanidine—Nervous system disorder—Capecitabine—colon cancer	0.00103	0.00106	CcSEcCtD
Tizanidine—Diarrhoea—Fluorouracil—colon cancer	0.00103	0.00105	CcSEcCtD
Tizanidine—Thrombocytopenia—Capecitabine—colon cancer	0.00103	0.00105	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Tizanidine—Tachycardia—Capecitabine—colon cancer	0.00103	0.00105	CcSEcCtD
Tizanidine—Vomiting—Vincristine—colon cancer	0.00103	0.00105	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—colon cancer	0.00102	0.00105	CcSEcCtD
Tizanidine—Skin disorder—Capecitabine—colon cancer	0.00102	0.00105	CcSEcCtD
Tizanidine—Rash—Vincristine—colon cancer	0.00102	0.00104	CcSEcCtD
Tizanidine—Hyperhidrosis—Capecitabine—colon cancer	0.00102	0.00104	CcSEcCtD
Tizanidine—Dermatitis—Vincristine—colon cancer	0.00102	0.00104	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—colon cancer	0.001	0.00102	CcSEcCtD
Tizanidine—Vomiting—Irinotecan—colon cancer	0.001	0.00102	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—colon cancer	0.000996	0.00102	CcSEcCtD
Tizanidine—Dizziness—Fluorouracil—colon cancer	0.000996	0.00102	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—colon cancer	0.000994	0.00102	CcSEcCtD
Tizanidine—Rash—Irinotecan—colon cancer	0.000992	0.00101	CcSEcCtD
Tizanidine—Dermatitis—Irinotecan—colon cancer	0.000991	0.00101	CcSEcCtD
Tizanidine—Hypotension—Capecitabine—colon cancer	0.000984	0.00101	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—colon cancer	0.000975	0.000998	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—colon cancer	0.000966	0.000989	CcSEcCtD
Tizanidine—Nausea—Vincristine—colon cancer	0.000959	0.000982	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000959	0.000982	CcSEcCtD
Tizanidine—Vomiting—Fluorouracil—colon cancer	0.000958	0.00098	CcSEcCtD
Tizanidine—Rash—Fluorouracil—colon cancer	0.00095	0.000972	CcSEcCtD
Tizanidine—Dermatitis—Fluorouracil—colon cancer	0.000949	0.000971	CcSEcCtD
Tizanidine—Paraesthesia—Capecitabine—colon cancer	0.000945	0.000967	CcSEcCtD
Tizanidine—Dyspnoea—Capecitabine—colon cancer	0.000938	0.000961	CcSEcCtD
Tizanidine—Nausea—Irinotecan—colon cancer	0.000934	0.000956	CcSEcCtD
Tizanidine—Back pain—Methotrexate—colon cancer	0.000929	0.000951	CcSEcCtD
Tizanidine—Dyspepsia—Capecitabine—colon cancer	0.000927	0.000948	CcSEcCtD
Tizanidine—Fatigue—Capecitabine—colon cancer	0.000908	0.000929	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—colon cancer	0.000905	0.000926	CcSEcCtD
Tizanidine—Constipation—Capecitabine—colon cancer	0.0009	0.000921	CcSEcCtD
Tizanidine—Nausea—Fluorouracil—colon cancer	0.000895	0.000916	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—colon cancer	0.000891	0.000912	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—colon cancer	0.000887	0.000908	CcSEcCtD
Tizanidine—Feeling abnormal—Capecitabine—colon cancer	0.000867	0.000888	CcSEcCtD
Tizanidine—Malaise—Methotrexate—colon cancer	0.000866	0.000886	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—colon cancer	0.000863	0.000883	CcSEcCtD
Tizanidine—Gastrointestinal pain—Capecitabine—colon cancer	0.000861	0.000881	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—colon cancer	0.000859	0.00088	CcSEcCtD
Tizanidine—Urticaria—Capecitabine—colon cancer	0.000836	0.000856	CcSEcCtD
Tizanidine—Body temperature increased—Capecitabine—colon cancer	0.000832	0.000852	CcSEcCtD
Tizanidine—Abdominal pain—Capecitabine—colon cancer	0.000832	0.000852	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—colon cancer	0.000832	0.000851	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—colon cancer	0.000817	0.000837	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000812	0.000831	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—colon cancer	0.000808	0.000827	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—colon cancer	0.00079	0.000809	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—colon cancer	0.000784	0.000802	CcSEcCtD
Tizanidine—Infection—Methotrexate—colon cancer	0.000779	0.000797	CcSEcCtD
Tizanidine—Hypersensitivity—Capecitabine—colon cancer	0.000776	0.000794	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—colon cancer	0.000768	0.000787	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—colon cancer	0.000767	0.000785	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—colon cancer	0.000761	0.000779	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—colon cancer	0.000758	0.000775	CcSEcCtD
Tizanidine—Asthenia—Capecitabine—colon cancer	0.000755	0.000773	CcSEcCtD
Tizanidine—Pruritus—Capecitabine—colon cancer	0.000745	0.000762	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—colon cancer	0.000732	0.000749	CcSEcCtD
Tizanidine—Diarrhoea—Capecitabine—colon cancer	0.00072	0.000737	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000714	0.000731	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—colon cancer	0.000704	0.00072	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—colon cancer	0.000699	0.000715	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—colon cancer	0.000697	0.000713	CcSEcCtD
Tizanidine—Dizziness—Capecitabine—colon cancer	0.000696	0.000712	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—colon cancer	0.00069	0.000706	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—colon cancer	0.000676	0.000691	CcSEcCtD
Tizanidine—Vomiting—Capecitabine—colon cancer	0.000669	0.000685	CcSEcCtD
Tizanidine—Rash—Capecitabine—colon cancer	0.000664	0.000679	CcSEcCtD
Tizanidine—Dermatitis—Capecitabine—colon cancer	0.000663	0.000679	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—colon cancer	0.000646	0.000661	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—colon cancer	0.000641	0.000656	CcSEcCtD
Tizanidine—Nausea—Capecitabine—colon cancer	0.000625	0.00064	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—colon cancer	0.000623	0.000637	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—colon cancer	0.000619	0.000634	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—colon cancer	0.000619	0.000634	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—colon cancer	0.000577	0.000591	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—colon cancer	0.000562	0.000575	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—colon cancer	0.000554	0.000567	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—colon cancer	0.000536	0.000549	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—colon cancer	0.000518	0.00053	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—colon cancer	0.000498	0.00051	CcSEcCtD
Tizanidine—Rash—Methotrexate—colon cancer	0.000494	0.000506	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—colon cancer	0.000494	0.000505	CcSEcCtD
Tizanidine—Nausea—Methotrexate—colon cancer	0.000465	0.000476	CcSEcCtD
